2018
DOI: 10.1177/1129729818762981
|View full text |Cite
|
Sign up to set email alerts
|

Cardiac implantable electronic device and vascular access: Strategies to overcome problems

Abstract: For arrhythmia treatment or sudden cardiac death prevention in hemodialysis patients, there is a frequent need for placement of a cardiac implantable electronic device (pacemaker, implantable cardioverter defibrillator, or cardiac resynchronization device). Leads from a cardiac implantable electronic device can cause central vein stenosis and carry the risk of tricuspid regurgitation or contribute to infective endocarditis. In patients with end-stage kidney disease requiring vascular access and cardiac implant… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
30
0
1

Year Published

2019
2019
2023
2023

Publication Types

Select...
7
2

Relationship

0
9

Authors

Journals

citations
Cited by 21 publications
(31 citation statements)
references
References 41 publications
0
30
0
1
Order By: Relevance
“…The mortality rate among dialysis patients depends on the type of vascular access and is higher in patients with catheters and fistulas made of artificial materials [1,4,17,22,[24][25][26][27]. Paradoxically, progress in medicine has led to an increase in infection rate by introducing artificial materials to build new vascular access.…”
Section: Discussionmentioning
confidence: 99%
“…The mortality rate among dialysis patients depends on the type of vascular access and is higher in patients with catheters and fistulas made of artificial materials [1,4,17,22,[24][25][26][27]. Paradoxically, progress in medicine has led to an increase in infection rate by introducing artificial materials to build new vascular access.…”
Section: Discussionmentioning
confidence: 99%
“…The risk varies between 9–26% of the cases, with either partial or complete occlusion, and it is higher in patients with chronic kidney disease and end stage renal disease who are on hemodialysis [911]. Therefore, the need for different approaches in such cases is imminent.…”
Section: Discussionmentioning
confidence: 99%
“…First, transvenous access for CIED should be avoided in patients likely needing HD in the short term, that is, those with rapid CKD progression and/or eGFR < 20 mL/min/1.73 m 2 . If transvenous CIED must be placed, the best strategy in the pre-dialysis patient will be AVF placement on the contralateral arm to CIED and avoidance of CVC if possible [10]. Second, the use of epicardial devices that traverse through the subcutaneous tissue and do not require vascular puncture, as the leads are inserted directly into the epicardium, could be implemented.…”
Section: Discussion/conclusionmentioning
confidence: 99%
“…The most common method of CIED insertion is the transvenous placement of the electrical leads, and the left subclavian or cephalic vein approach is preferred by many implanting physicians for CIED lead insertion, due to favorable venous anatomy and optimal shock vectors for ICD therapy. When a vascular access is required, the presence of electrical leads in the central veins could be associated with vascular and infectious complications, which demands an individual approach in access creation [10]. Patients with a pacemaker or an ICD show a similar risk of venous obstruction.…”
Section: Discussion/conclusionmentioning
confidence: 99%